EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Sunrise of Tertiary Lymphoid Structures in Cancer

Juliette Rochefort, Gilles Marodon, Jean-Luc Teillaud, Marie-Caroline Dieu-Nosjean iD

Immunological Reviews · 2025-07 · 332 (1)

DOI: 10.1111/imr.70046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2025-07. Verfasst von Juliette Rochefort und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inserm U1135, Paris, France. Hauptthemen laut MEDLINE: Neoplasms, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Institut National Du Cancer, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First considered as a negative epiphenomenon in autoimmune and inflammatory diseases, with possible deleterious consequences through the production of pathological autoantibodies and antiself T cells, tertiary lymphoid structures (TLS) have gained major scientific and clinical interest in cancer due to their association with better clinical outcomes and improved responses to immunotherapy. Studies have investigated the structure and plasticity of TLS in the context of tumors and the role of the TLS B‐cell compartment in contributing to the favorable clinical outcome of cancer patients. Identifying biomarkers that indicate the presence of TLS in tumors in a noninvasive manner could therefore represent a major advance in the diagnosis and treatment decision‐making for these patients. Also, the interplay between TLS, tumor cells, and microbiota opens new avenues for deciphering the role of microorganisms in cancer development. Their use as TLS inducers further underlines the need for continued research in this field. Moreover, emerging data have emphasized the critical role of sensory and sympathetic nerves in regulating TLS formation and function. Finally, humanized mice may serve as valuable tools for developing preclinical models to study the role of human TLS in cancer, a much‐needed goal. These different topics are discussed in the present review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTertiary Lymphoid StructuresHumansAnimalsTumor MicroenvironmentImmunotherapyB-Lymphocytes

Stichwörter der Autor:innen

biomarkerhumanized mousemicrobiotasensory nervesympathetic nervetertiary lymphoid structure

Autor:innen und Institutionen

  • Inserm U1135, Paris, France.
  • Sorbonne University, UMRS1135, Paris, France.
  • Laboratory "Immune Microenvironment and Immunotherapy", Center of Immunology and Microbial Infections (Cimi), Faculty of Health, Sorbonne University, Paris, France.
  • Health Faculty, UFR Odontologie, University of Paris, Paris, France.
  • Department of Odontology, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Department of Odontology, Paris Cité University, Paris, France.

ORCID-Profile: Marie-Caroline Dieu-Nosjean

Förderung

  • Wellcome Trust
  • Institut National Du Cancer
  • AstraZeneca
  • Inserm Transfert
  • Institut National de la Santé et de la Recherche Médicale (Inserm) recurrent grant
  • Cancéropole Ile-de-France
  • Ligue Nationale contre le Cancer
  • Sorbonne Université recurrent grant

Zitieren

APA

Rochefort, J., Marodon, G., Teillaud, J. L., & Dieu-Nosjean, M. C. (2025). The Sunrise of Tertiary Lymphoid Structures in Cancer. Immunological Reviews, 332(1). https://doi.org/10.1111/imr.70046

Vancouver

Rochefort J, Marodon G, Teillaud JL, Dieu-Nosjean MC. The Sunrise of Tertiary Lymphoid Structures in Cancer. Immunological Reviews. 2025;332(1). doi:10.1111/imr.70046

BibTeX
@article{Rochefort2025,
  author = {Rochefort, Juliette and Marodon, Gilles and Teillaud, Jean-Luc and Dieu-Nosjean, Marie-Caroline},
  title = {The Sunrise of Tertiary Lymphoid Structures in Cancer},
  journal = {Immunological Reviews},
  year = {2025},
  volume = {332},
  number = {1},
  doi = {10.1111/imr.70046}
}
Kostenlos starten →